Efficacy and safety trial of AJG555 in patients with chronic constipation (Phase 3 study)

Trial Profile

Efficacy and safety trial of AJG555 in patients with chronic constipation (Phase 3 study)

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs AJG 555 (Primary)
  • Indications Constipation
  • Focus Registrational; Therapeutic Use
  • Sponsors Ajinomoto Pharma; EA Pharma
  • Most Recent Events

    • 05 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 02 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 13 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top